Puma Biotechnology Inc expected to post a loss of 7 cents a share - Earnings Preview

Puma Biotechnology

03/05/2023 03:07

* Puma Biotechnology Inc  PBYI.OQ   PBYI.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 4. 
    * The Los Angeles California-based  company is expected to
report 
a 8.6% increase in revenue to $49.633 million from $45.7 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Puma Biotechnology
Inc is
for a loss of 7 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 2 "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 9.5%
in the last three months. ​
    * Wall Street's median 12-month price target for Puma
Biotechnology Inc is $5​, above​ its last closing price
of $2.65. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  0.05        0.05       -0.12     Missed  -340
 Sep. 30 2022  -0.06       -0.05      -0.01     Beat    81.8
 Jun. 30 2022  0.01        0.01       0.21      Beat    1,958.
                                                        8​
 Mar. 31 2022  -0.16       -0.17      -0.08     Beat    51.8
 ​​Dec.        -0.08       -0.09      0.10      Beat    214.2
 31 2021                                                
 Sep. 30 2021  -0.32       -0.31      -0.90     Missed  -188.8
                                                        ​
 Jun. 30 2021  -0.25       -0.27      -0.13     Beat    52.1
 Mar. 31 2021  0.16        0.09       0.40      Beat    359.8
 This summary was machine generated May 3 at 02:07 GMT.  All
figures in US dollars  unless otherwise stated